Galectin Therapeutics GALT
NASDAQ GALT
$3.38 +0.01 (+0.30%)
At close: Oct 22, 2026 · 4:00 PM EDT

Galectin Therapeutics (GALT) Total Debt (2024 - 2026)

Updated

Galectin Therapeutics' Total Debt was $33.04 million in Q2 2026.

Analysis

Galectin Therapeutics (GALT) Total Debt (2024 - 2026) Analysis & Trends

At the end of FY2024, Total Debt at Galectin Therapeutics came in at $21.12 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 54.91 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 44.65 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 70.82 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 53.91 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 9.59 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 32.35 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 57.30 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 26.25 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 63.19 Bn
10 Galectin Therapeutics 223.32 Mn 166.66 Mn - 33.04 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 33.04 Mn
Sep 30, 2025 32.52 Mn
Mar 31, 2025 21.28 Mn
Dec 31, 2024 21.12 Mn
Sep 30, 2024 10.52 Mn
API Access

Galectin Therapeutics Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=GALT&period=max&api_key=YOUR_API_KEY